510(k) Summary

Prepared October 23, 2008

K083162
STINGRAY SURGICAL PRODUCTS INC

801 APPLE TREE LANE

BOCA RATON, FL 33486
Tel 561-210-7582
Fax 561-210-5608

Contact: Mark McBrinn, President

1. Identification of the Device:

Proprietary-Trade Name: Stingray Electrosurgical Forceps

Classification Name: Electrosurgical cutting and coagulation device and accessories
Product Codes Product Code GEI

Common/Usual Name: Bipolar Forceps

2. Equivalent legally marketed devices: ProMed Instruments GmbH DORO® Non-Stick
Bipolar Forceps K070997

3. Indications for Use (intended use) Designed to grasp, manipulate and coagulate selected
tissue for use in general surgical procedures, They are connected through a suitable bipolar
cable with the bipolar output of an electrosurgical generator. Bipolar forceps must only be
used with bipolar coagulation current. Coagulation is achieved using electrosurgical energy
generated by the electro surgical generator unit and activated by a footswitch. The Stingray
Forceps have not been shown to be effective for tubal sterilization or tubal coagulation for
sterilization procedures and should not be used for these procedures.

4. Description of the Device: These devices are bipolar forceps design for use in general
surgical procedures, They are connected through a suitable bipolar cable with the bipolar
output of an electrosurgical generator. The forceps are designed to grasp and manipulate
selected tissues. Coagulation is achieved using electrosurgical energy generated by the
electrosurgical generator unit and activated by a footswitch. They are constructed of stainless
steel, a nylon coating, and a non-stick tip. The devices are provided non-sterile and must be
autoclaved prior to use.

5. Safety and Effectiveness, comparison to predicate device. The results of bench and standards
testing indicates that the new device is as safe and effective as the predicate devices.

: Page 15 of 133

KOS 3162 fase » f ©
oy 6. Substantial Equivalence Chart
Non-Stick Bipolar Forceps K070997 Forceps
intended Use:___—_—_—'| Bipolar electrosurgical procedures [SAME
—— a
steel, and non-stick plated tip
[Generator «| Bipolar electrosurgical’ Ss CSAME
[Connector | 2 pin bipolar, insulated SAME
| Materials | Nylonccoated stainless steel S| SAME
[Sterilization Autoclave CT SAME
[Bee
2-2: Particular requirements for the safety of
high frequency surgical equipment
= es per
Devices :
7, Conclusion 0 ,
After analyzing bench and standards testing data, it is the conclusion of Stingray Surgical Inc. that the
Stingray Electrosurgical Forceps are as safe and effective as the predicate devices, have few
technological differences, and have no new indications for use, thus rendering them substantially
equivalent to the predicate devices. .
Page 16oft33

are :
f DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
: @ :
% _—_— OO
hen . .
Food and Drug Administration
. 9200 Corporate Boulevard
. Rockville MD 20850
Stingray Surgical Products, Inc. . oe .
% Kamm & Associates
Mr. Daniel Kamm, PE. JAN 12 2009 :
P.O. Box 7007. .
Deerfield, Illinois 60015 :
Re: K083162 .
-  Trade/Device Name: Stingray Electrosurgical Forceps :
Regulation Number: 21 CFR 878.4400 Lo
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: II .
Product Code: GEI
. Dated: December 17, 2008 :
. Received: December 23, 2008 : : .
Dear Mr. Kamm: .
We have reviewed your Section $10(k) premarket notification of intent to market the device ‘
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in'the enclosure) to legally marketed predicate devices marketed in interstate /
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to *
"devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
‘ and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
: You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and ,
'* adulteration. .
: If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to such additional controls, Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may . :
publish further-announcements concerning your device in the Federal Register,
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
’ CER Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set .
forth in the quality systems (QS) regulation (21 CFR Part-820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

l
- |
‘ : |
I
Page 2 — Mr. Daniel Kamm, P.E. : . , ‘ |
‘This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification, The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market, . . oo
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please. contact the Center for Devices and Radiological Health’s (CDRH’s) Office of Compliance at
(240) 276-0115. Also, please note the regulation entitled, “Misbranding by reference to . |
premarket notification” (21CFR Part 807.97), For questions regarding postmarket surveillance, t
please contact CDRH’s Office of Surveillance and Biometric’s (OSB’s) Division of Postmarket }
. Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events
(Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems i
at (240) 276-3464. You may obtain other general information on your responsibilities under the : |
; Act from the Division of Small Manufacturers, International and Consumer Assistance ,
at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address .
http://www. fda.gov/edrh/industry/support/index,html, :
: Sincerely yours, :
Mark N. Melkerson . : . :
: . Director _ .
, ‘ . Division of General, Restorative :
: , and Neurological Devices
, Office of Device Evaluation : .
: Center for Devices and
; Radiological Health :
Enclosure . .

, . Indications for Use ‘
, 510(k) Number (if known):__K08 3162 _ . :
"Device Name; Stingray Electrosurgical Forceps . .
Indications For Use: :
Designed to grasp, manipulate and coagulate selected tissue for use in general surgical procedures. They
are connected through a suitable bipolar cable with the bipolar output of an electrosurgical generator.
, Bipolar forceps must only be used with bipolar coagulation current. Coagulation is achieved using . :
electrosurgical energy generated by the electro surgical generator unit and activated by a footswitch. The
Stingray Forceps have not been shown to be effective for tubal sterilization or tubal coagulation for
sterilization procedures and should not be used for these procedures. :
i . :
. Prescription Use X AND/OR Over-The-Counter Use co,
*  @art 21 CPR 801 Subpart D) . (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluition(ODE) =
. . Page lof 1.”
. € . .
_ (ivision Sign-Off) .
oO . . Division of General, Restorative, © . So
and Neurological Devices a
- 510(k) Number Kos 3162 . et
. . Page 140133

